AI assistant
Sending…
Brainsway Ltd. — Board/Management Information 2021
May 5, 2021
6701_rns_2021-05-05_e433e616-7741-4c72-98de-acff3c6b410e.htm
Board/Management Information
Open in viewerOpens in your device viewer
BrainsWay Announces Appointment of R. Scott Areglado as SVP and CFO false
| ���������� ��"� | 2 380 |
| BRAINSWAY LTD | |
| Corporation no: 513890764 | 10767 |
| - - - | |
| Israel Securities Authority | Tel Aviv Stock Exchange | C002 ( Public ) | Reported via MAGNA: | 04/05/2021 | ||||||
| www.isa.gov.il | www.tase.co.il | Reference: | 2021-02-077457 | Time of broadcast: 12:03 12:03 |
Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
| The corporation is a foreign private issuer as defined by U.S. Securities Laws. |
Attached hereto is a report onBrainsWay Announces Appointment of R. Scott Areglado as SVP and CFO
BrainsWay_Announces_Appointment_of_R_Scott_Areglado_as_SVP_and_CFO_isa.pdf
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | |
| - - - | |
| Stock Exchange/Market: BWAY | Date of revision of form structure: 20/04/2021 |
| Address: ����� 19 , ������� 91451 , Tel: 02-5813140 , Fax: 02-5812517 | |
| E-mail address: [email protected] Company site: www.Brainsway.com | |
| Previous names of reporting entity: | |
| Name of the Signatory: Levy Hadar Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: | |
| Address: Hartum Street, Bynet Building 19 , Jerusalem 9777518 Telephone: 97225824030 Facsimile: 97225812517 E-mail: [email protected] 1 | |
More from Brainsway Ltd.
Director's Dealing
2026
May 21
Director's Dealing
2026
May 21
Regulatory Filings
2026
May 18
Report Publication Announcement
2026
May 18
Report Publication Announcement
2026
May 13
Investor Presentation
2026
May 13
Interim / Quarterly Report
2026
May 13
Report Publication Announcement
2026
May 13
Report Publication Announcement
2026
Apr 20
Regulatory Filings
2026
Apr 20